Jiangxi longkaihe Pharmaceutical Technology Group Co., Ltd. (hereinafter referred to as longkaihe group) was established on July 27, 2011 with the investment of Jiangxi Guangling Pharmaceutical Co., Ltd. (established in April 2009). The company is located in No.3 Park, Chengdong Industrial base, Xiyang District, Jiujiang City, covering an area of 24.79 mu, with a registered capital of 100 million yuan. Longkaihe group is a comprehensive pharmaceutical technology service provider, integrating the wholesale and retail of drugs and medical devices, planting of traditional Chinese medicine, deep processing of Chinese herbal medicine, production and sales, R & D and production of masks. Health food sales, general merchandise, food and medical supplies online sales. On September 17, 2019, the company successfully listed on the new third board and was selected as Jiangxi provincial reserve enterprise with stock code of 873353. Longkaihe group owns Jiangxi Guangling Pharmaceutical Co., Ltd. (wholesale of medical devices); Jiujiang henggeli Medical Technology Co., Ltd. (producing masks); Jiangxi Guangzhu herbal medicine products Co., Ltd. (producing herbal tablets); Jiangxi Guangling pharmacy chain Co., Ltd. (drug retail, with 57 chain pharmacies); Jiangxi longkaihe Health Industry Co., Ltd. (producing health food) Jiangxi Yijiatong e-commerce Co., Ltd. (online commodity sales) and 3500 mu of Chinese herbal medicine planting base and other six wholly-owned subsidiaries. Longkaihe group has 510 employees and fixed assets of 450 million yuan. It is the largest pharmaceutical enterprise in Jiujiang City. It has won the "big taxpayer Award", "target task completion Award" and "outstanding contribution award of key enterprises" issued by the local government, and has been rated as "excellent enterprise of Jiujiang City" for five consecutive years. The company has won the honors of "Jiangxi Province contract abiding and trustworthy unit", "Jiangxi top ten logistics growth enterprises", "Jiangxi Province's benchmark enterprise of two times of modernization deep integration"; longkaihe's registered trademark won the honor of "Jiangxi Province's contract abiding and credit worthy unit". Longkaihe group is one of the rapidly developing enterprises in Jiujiang City. It has successively undertaken three key new products in Jiangxi Province, including one Municipal Science and technology project, two municipal technology transformation projects, and more than 40 patents, including one invention patent, 16 utility model patents, 12 software copyrights, and 12 brands, logos and logos. Longkaihe group always adheres to the enterprise tenet of "to be a good man, to be a man with conscience, to help the world with love", and to practice the business philosophy of "splendid Longzhang, carrier of man-made Fuhe River". "Connecting the world" has always taken inheriting the fine medical ethics and exquisite medical technology of the Chinese nation as its own responsibility, taking strengthening the medical industry as the ideal, practicing people-oriented, and benefiting all mankind. Integrating resources that are conducive to the development of enterprises, gathering excellent talents, and seeking win-win situation for all parties. Jiujiang henggeli Medical Technology Co., Ltd. (hereinafter referred to as henggeli) is one of the wholly-owned subsidiaries of longkaihe group. It was established in April 2011 with a registered capital of 1.18 million yuan and settled in No.3 Park, Chengdong Industrial base, X Yang District, Jiujiang City. Mainly engaged in the first-class medical equipment, second-class medical equipment production and sales, as well as labor protection supplies research and development, production and sales. In response to government advocates, hangley has increased $10 million in mask production investment to ease mask shortages. The company has established a new mask production plant with a total construction area of 2700 square meters and a daily production capacity of 1.5 million secondary protective masks. Henggeli medical mask production project passed the online approval and supervision platform of Jiangxi investment project on February 17. Henggli medical disposable protective mask is produced according to the national standard technical specification for daily protective masks (GB / t32610-2016) and health standards. Enterprise standard for disposable daily protective masks (Q / 421202hgl001-2020). The product passed the FDA certification in March 2020 and has export qualification. At present, it is applying for t ü V certification and is expected to obtain certification in mid May.